Cell and gene therapies (CGT’s) are rapidly transforming medical care and treatments. These processes use modified cells or cellular matter to treat, prevent or cure serious health issues such as cancer, genetic disorders, immunodeficiencies, and rare diseases.

The Maryland Stem Cell Research Fund (MSCRF) has invested over $170 million in Maryland to support this industry and accelerate cures.

Our panel will discuss the technologies themselves as well as their applications. Panelists will also explore on the impact of these advances on human life. This panel is designed to appeal both to those who work in this space and those who want to learn more about it.

Amritha Jaishankar, PhD
Executive Director, Maryland Stem Cell Research Fund (MSCRF)

Vered Caplan
Chief Executive Officer, Orgenesis, Inc

Darryl L. Carter, MD
Venture Advisor, University of Maryland, Baltimore
Co-Founder, Otter Imuno-Oncology, LLC